Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2019-10-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
独立董事关于第四届董事会第二十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 24th meeting of the 4th board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It references compliance with regulatory guidelines and company bylaws, and discusses a change in accounting policy. The document is a formal opinion statement by independent directors rather than a full financial report or audit report. It does not contain financial statements or detailed financial data, nor is it an announcement of a meeting or voting results. It is not a certification or a regulatory filing in the narrow sense but a board/management related document expressing independent directors' views on board matters. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on board opinions, not a full report or announcement.
2019-10-25 Chinese
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a change in accounting policies. It references a specific regulatory notice from the Ministry of Finance dated September 27, 2019, about revisions to consolidated financial statement formats. The document details the nature of the accounting policy changes, their impact on financial statement line items, and includes opinions from independent directors and the supervisory board. The document is relatively short (1912 characters) and does not contain actual financial statements or detailed financial data. Instead, it is a formal announcement about the change in accounting policies and related approvals. This fits best under Regulatory Filings (RNS), as it is a regulatory announcement and does not constitute a full audit report or annual/interim report.
2019-10-25 Chinese
2019年第三季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (392 characters) indicating that the company's 2019 third quarter report has been published and is available on a regulatory website. It does not contain the actual financial data or substantive analysis from the report itself, but rather directs investors to where the report can be found. According to the 'MENU VS MEAL' rule, such a brief notice that a report is published and available elsewhere should be classified as a Report Publication Announcement (RPA), not as the Interim/Quarterly Report (IR) itself.
2019-10-25 Chinese
第四届监事会第十六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. It includes approval of a change in accounting policy and the review and approval of the company's 2019 third quarter report. The document itself does not contain the full financial statements or detailed financial data of the quarterly report but refers readers to the full 2019 third quarter report published on the designated disclosure website. The document length is short (1083 characters) and serves as an announcement of the Supervisory Board's meeting resolutions and approval of the quarterly report rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement related to an interim/quarterly report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement of meeting resolutions and report approval without substantive financial data included.
2019-10-25 Chinese
第四届董事会第二十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from Guangzhou Yangpu Medical Technology Co., Ltd. It includes the approval of a change in accounting policy and the approval of the 2019 third quarter report. The document states that the board has reviewed and approved the 2019 third quarter report, which reflects the company's actual operating conditions and results. The document is relatively short (1100 characters) and references the full 2019 third quarter report being available on the designated disclosure website. This indicates that the document itself is not the full interim/quarterly report but an announcement of the board's approval of that report. Therefore, it fits best as a Regulatory Filing (RNS) because it is a formal announcement of board resolutions and report approval rather than the full report or detailed financial statements themselves.
2019-10-25 Chinese
2019年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "广州阳普医疗科技股份有限公司 2019 年第三季度报告" which translates to "Guangzhou Yangpu Medical Technology Co., Ltd. 2019 Third Quarter Report." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and analysis of financial indicators for the third quarter of 2019. The document includes comprehensive financial figures, explanations of changes in financial data, shareholder information, and important events during the reporting period. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The presence of quarterly financial statements and detailed management discussion aligns with the definition of an Interim / Quarterly Report (IR). There is no indication that this is an announcement of a report or a certification document, so it is not RPA or RNS. Therefore, the document is classified as an Interim / Quarterly Report (IR). Q3 2019
2019-10-25 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.